Background:  This is a multicenter, randomized, double-blind, active-controlled study to evaluate the effects of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction Sponsor: Novartis Trial Registration No: NCT02884206 ( Link  Trial Status: Recruitment stopped Enrolling Centers:  Worldwide: multicentric  Core Study Team: 
© Christian Mueller, 2012 - 2020 │  Disclaimer  │  Imprint  │  Webmaster │ Last Update: July 2020
Home News Team Studies Publications Events Cooperations Contact Ina-Maria Ferel, Ph.D. Eleni Michou Sabrina Stefanelli Dr. Samyut Shretha Kathrin Leu Nicola Häni Beate Hartmann, Ph.D Kristin Shrestha